The Embolization Particle market is gaining traction in prostate artery embolization procedures. Growing clinical interest in minimally invasive treatment options for benign prostatic hyperplasia is creating additional opportunities. The embolization particle market size is expected to reach US$ 9.25 billion by 2034 from US$ 2.67 billion in 2025, registering a strong CAGR of 14.80% during...